TOP GLOVE CORPORATION BHD Corporate Presentation May 2018 Bursa Malaysia : 7113 SGX : BVA Reuters : TPGC.KL Bloomberg : TOPG MK ADR CUSIP : 890534100
Top Glove business ethics Ready, 1 2 3 Claps, 2x 3x2x Prepared By: Ng Chin Yong @14/07/17 Checked & Verified By: Ng Yong Lin @14/07/17 2
Disclaimer This document and any related presentations have been prepared by Top Glove Corporation Bhd (the “Company”) . This document and any related presentations are being given solely for your information and for your use and may not be taken away, reproduced or redistributed to any other person. By attending this presentation, you are agreeing to be bound by these restrictions. Any failure to comply with these restrictions may constitute a violation of applicable securities laws. The information contained in this document (the “Information”) is strictly confidential and has been provided by the Company and has not been independently verified. No representation or warranty express or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained herein. It is not the intention to provide, and you may not rely on this document as providing, a complete or comprehensive analysis of the Company’s business, financial condition, results of operations, trading position or prospects. The Information and opinions in this document are provided as at the date of this document and are subject to change without notice. Neither the Company nor any of its affiliates, advisors or representatives shall have any liability whatsoever (in negligence or otherwise) for any loss howsoever arising from any use of this document or its contents or otherwise arising in connection with this document. Certain data in this document was obtained from various external data sources, and the Company has not verified such data with independent sources. Accordingly, the Company makes no representations as to the accuracy or completeness of that data, and such data involves risks and uncertainties and is subject to change based on various factors. This document contains, and any related presentations may contain, financial information regarding the businesses and assets of the Company and its consolidated subsidiaries. Such financial information may not have been audited, reviewed or verified by any independent accounting firm. The inclusion of such financial information in this document or any related presentation should not be regarded as a representation or warranty by the Company, any of its affiliates, advisors or representatives or any other person as to the accuracy or completeness of such information’s portrayal of the business, financial condition, results of operations, trading position or prospects by the Company and should not be relied upon when making an investmentdecision. This document includes forward-looking statements prepared by the Company. The opinions, forecasts, projections and other statements (except statements of historical fact), including, without limitation, financial results for 1HFY2018, are forward-looking statements. Although the Company believes that the expectations reflected in such forward- looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. All forward-looking statements contained in this document are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Each forward-looking statement speaks only as of the date of this document. Neither the Company nor any of its affiliates, advisors or representatives undertakes any obligation to publicly update or revise any forward-looking statement as a result of new information, future events or other information. In light of these risks, actual results could differ materially from those stated, implied or inferred from the forward- looking statements contained in thisdocument. This document and any related presentation does not constitute or form part of an offer, solicitation or invitation of any offer, to subscribe for or purchase any securities and nothing contained herein shall form the basis of, or be relied on, in connection with any contract or commitment whatsoever. Any decision to purchase securities in the context of a proposed offering undertaken in the future by the Company, if any, should be made on the basis of information contained in the offering document published in relation to such an offering. Any securities offered by the Company or any of its subsidiaries will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”) and may not be offered or sold in the United States absent registration under the Securities Act or an applicable exemption to registration. Any securities offered by the Company or any of its subsidiaries will be offered to (1) persons in Labuan or outside Malaysia or entities established or registered under the laws of Labuan and (2) persons falling within the categories of excluded offers and invitations of debentures as set out in Section 8(5) of the Labuan Financial Services and Securities Act 2010 ("LFSSA"). This document, any related presentation or any copy thereof may not be taken or transmitted or distributed, directly or indirectly, into the United States, Canada, Australia or Japan. The Company does not intend to register any offering of securities in the United States or conduct any public offering of securities in the United States. The distribution of this document and any related presentation in other jurisdictions may be restricted by law and persons into whose possession this document or any related presentation comes should inform themselves about, and observe, any such restriction. Any failure to comply with these restrictions may constitute a violation of the laws of any such other jurisdiction. 3
Top Glove Corporation Bhd (“Top Glove”) at a glance World’s largest manufacturer of gloves Global leader in Aspion: medical and a transformational surgical gloves acquisition 57.5 billion gloves pa 2,000+ customers Over 17,000 38 factories across 195 employees (1) 618 production countries lines (1) Current market FY17 Revenue of capitalisation (2) of RM3.4bn (USD 882mn) RM13.0bn and PATMI of RM0.3bn (USD 3.30bn) (USD85mn) (3) Source: Bloomberg Notes: Include Aspion Sdn Bhd (“Aspion”) (1) 4 (2) Market capitalisation as at 14 May 2018. Translated at FX rate of USD1:RM3.9345 for convenience (3) Based on Top Glove’s consolidated financial results for FYE 31 Aug 2017. Excludes Aspion (RM0.6bn (USD162mn) revenues for FYE 31 Oct 2016). PATMI refers to profit after tax and minority interests. Translated at FX rate of USD1:RM3.8643 for convenience
From humble origins to global leader Nearly 3 decades of track record of excellence 1991 1994 2001 2002 ▪ ▪ ▪ ▪ Started asa First overseas foray Commenced operations inThailand Commenced operationsin ▪ local and established a China Listed on the Second Board of business ▪ marketing arm inthe Kuala Lumpur StockExchange Established a secondrubber (“KLSE”) enterprise USA glovefactory in Thailand ▪ Transferred to the Main Board of KLSE 2010 2006 ▪ ▪ Revenues over RM2bn Acquisition of amajority stake in Medi-Flex 2011 2013 ▪ Acquired a marketingarm 2007 ▪ Established first ▪ in Germany to extend Revenues over RM1bn dedicated GroupR&D sales in Europe Centre to drive innovation ▪ Acquisition of the remaining minority stake in Medi-Flex and privatisation of the 2016 2017 2018 ▪ company ▪ ▪ Investment in new Secondary listing on Acquisition of Aspion business line- condom ▪ Singapore Stock Acquisition of EasternPress Exchange (“SGX”) projected to beoperational ▪ Proposed acquisition of by mid-2018 Duramedical ▪ Revenues overRM3bn (USD776mn) (1) Note: (1) Translated at FX rate of USD1:RM3.8643 for convenience 5
Recommend
More recommend
